Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer

Gastrointestinal cancers (GICs) remain the most diagnosed cancers and accounted for the highest cancer-related death globally. The prognosis and treatment outcomes of many GICs are poor because most of the cases are diagnosed in advanced metastatic stages. This is primarily attributed to the deficie...

Full description

Bibliographic Details
Main Authors: Md Zahirul Islam Khan, Shing Yau Tam, Helen Ka Wai Law
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/6/973
_version_ 1797472343688216576
author Md Zahirul Islam Khan
Shing Yau Tam
Helen Ka Wai Law
author_facet Md Zahirul Islam Khan
Shing Yau Tam
Helen Ka Wai Law
author_sort Md Zahirul Islam Khan
collection DOAJ
description Gastrointestinal cancers (GICs) remain the most diagnosed cancers and accounted for the highest cancer-related death globally. The prognosis and treatment outcomes of many GICs are poor because most of the cases are diagnosed in advanced metastatic stages. This is primarily attributed to the deficiency of effective and reliable early diagnostic biomarkers. The existing biomarkers for GICs diagnosis exhibited inadequate specificity and sensitivity. To improve the early diagnosis of GICs, biomarkers with higher specificity and sensitivity are warranted. Proteomics study and its functional analysis focus on elucidating physiological and biological functions of unknown or annotated proteins and deciphering cellular mechanisms at molecular levels. In addition, quantitative analysis of translational proteomics is a promising approach in enhancing the early identification and proper management of GICs. In this review, we focus on the advances in mass spectrometry along with the quantitative and functional analysis of proteomics data that contributes to the establishment of biomarkers for GICs including, colorectal, gastric, hepatocellular, pancreatic, and esophageal cancer. We also discuss the future challenges in the validation of proteomics-based biomarkers for their translation into clinics.
first_indexed 2024-03-09T20:00:32Z
format Article
id doaj.art-001f2ab0d42842ba9e27e82bb24b2325
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T20:00:32Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-001f2ab0d42842ba9e27e82bb24b23252023-11-24T00:44:04ZengMDPI AGCells2073-44092022-03-0111697310.3390/cells11060973Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal CancerMd Zahirul Islam Khan0Shing Yau Tam1Helen Ka Wai Law2Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong, ChinaDepartment of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong, ChinaDepartment of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong, ChinaGastrointestinal cancers (GICs) remain the most diagnosed cancers and accounted for the highest cancer-related death globally. The prognosis and treatment outcomes of many GICs are poor because most of the cases are diagnosed in advanced metastatic stages. This is primarily attributed to the deficiency of effective and reliable early diagnostic biomarkers. The existing biomarkers for GICs diagnosis exhibited inadequate specificity and sensitivity. To improve the early diagnosis of GICs, biomarkers with higher specificity and sensitivity are warranted. Proteomics study and its functional analysis focus on elucidating physiological and biological functions of unknown or annotated proteins and deciphering cellular mechanisms at molecular levels. In addition, quantitative analysis of translational proteomics is a promising approach in enhancing the early identification and proper management of GICs. In this review, we focus on the advances in mass spectrometry along with the quantitative and functional analysis of proteomics data that contributes to the establishment of biomarkers for GICs including, colorectal, gastric, hepatocellular, pancreatic, and esophageal cancer. We also discuss the future challenges in the validation of proteomics-based biomarkers for their translation into clinics.https://www.mdpi.com/2073-4409/11/6/973biomarkersgastrointestinal cancermass spectrometryproteomicsmulti-omics
spellingShingle Md Zahirul Islam Khan
Shing Yau Tam
Helen Ka Wai Law
Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer
Cells
biomarkers
gastrointestinal cancer
mass spectrometry
proteomics
multi-omics
title Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer
title_full Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer
title_fullStr Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer
title_full_unstemmed Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer
title_short Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer
title_sort advances in high throughput proteomics profiling in establishing potential biomarkers for gastrointestinal cancer
topic biomarkers
gastrointestinal cancer
mass spectrometry
proteomics
multi-omics
url https://www.mdpi.com/2073-4409/11/6/973
work_keys_str_mv AT mdzahirulislamkhan advancesinhighthroughputproteomicsprofilinginestablishingpotentialbiomarkersforgastrointestinalcancer
AT shingyautam advancesinhighthroughputproteomicsprofilinginestablishingpotentialbiomarkersforgastrointestinalcancer
AT helenkawailaw advancesinhighthroughputproteomicsprofilinginestablishingpotentialbiomarkersforgastrointestinalcancer